Global Metronidazole Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Metronidazole Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Metronidazole Injection is a sterile, parenteral dosage form of metronidazole in water. Metronidazole is classified as a synthetic antibacterial and antiprotozoal agent and is administered by the intravenous route. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Metronidazole Injection and other antibacterial drugs, Metronidazole Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection.
Metronidazole Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Metronidazole Injection market is projected to reach US$ 30 million in 2034, increasing from US$ 32 million in 2022, with the CAGR of -1.2% during the period of 2024 to 2034. Demand from Adult Use and Pediatric Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Metronidazole Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Metronidazole Injection key manufacturers include Pfizer, B. Braun Medical Inc, Sanofi-Aventis Canada Inc, Baxter, JB Chemicals and Pharmaceuticals, Qatar Pharma, Unique Pharmaceuticals, Sagent Pharmaceuticals and AdvaCare Pharma, etc. Pfizer, B. Braun Medical Inc, Sanofi-Aventis Canada Inc are top 3 players and held % sales share in total in 2022.
Metronidazole Injection can be divided into 500mg/100mL and 50mg/10mL, etc. 500mg/100mL is the mainstream product in the market, accounting for % sales share globally in 2022.
Metronidazole Injection is widely used in various fields, such as Adult Use, Pediatric Use and Geriatric Use,, etc. Adult Use provides greatest supports to the Metronidazole Injection industry development. In 2022, global % sales of Metronidazole Injection went into Adult Use filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Metronidazole Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma
Segment by Type
500mg/100mL
50mg/10mL
Adult Use
Pediatric Use
Geriatric Use
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Metronidazole Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Metronidazole Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Metronidazole Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Metronidazole Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Metronidazole Injection introduction, etc. Metronidazole Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Metronidazole Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Metronidazole Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Metronidazole Injection market is projected to reach US$ 30 million in 2034, increasing from US$ 32 million in 2022, with the CAGR of -1.2% during the period of 2024 to 2034. Demand from Adult Use and Pediatric Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Metronidazole Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Metronidazole Injection key manufacturers include Pfizer, B. Braun Medical Inc, Sanofi-Aventis Canada Inc, Baxter, JB Chemicals and Pharmaceuticals, Qatar Pharma, Unique Pharmaceuticals, Sagent Pharmaceuticals and AdvaCare Pharma, etc. Pfizer, B. Braun Medical Inc, Sanofi-Aventis Canada Inc are top 3 players and held % sales share in total in 2022.
Metronidazole Injection can be divided into 500mg/100mL and 50mg/10mL, etc. 500mg/100mL is the mainstream product in the market, accounting for % sales share globally in 2022.
Metronidazole Injection is widely used in various fields, such as Adult Use, Pediatric Use and Geriatric Use,, etc. Adult Use provides greatest supports to the Metronidazole Injection industry development. In 2022, global % sales of Metronidazole Injection went into Adult Use filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Metronidazole Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma
Segment by Type
500mg/100mL
50mg/10mL
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Metronidazole Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Metronidazole Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Metronidazole Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Metronidazole Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Metronidazole Injection introduction, etc. Metronidazole Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Metronidazole Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices